The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

ELIGARD 7.5 mg powder and solvent for solution for injection

Recordati Industria Chimica e Farmaceutica SpAPA0812/005/001

Main Information

Trade NameELIGARD 7.5 mg powder and solvent for solution for injection
Active SubstancesLeuprorelin acetate
Dosage FormPowder and solvent for solution for injection
Licence HolderRecordati Industria Chimica e Farmaceutica SpA
Licence NumberPA0812/005/001

Group Information

ATC CodeL02AE Gonadotropin releasing hormone analogues
L02AE02 leuprorelin


License statusAuthorised
Licence Issued13/10/2005
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back